Medicare Enrolled

Dr. Michael Dao, M.D.

Family Medicine · Garden Grove, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
14362 BROOKHURST ST, Garden Grove, CA 92843
7145317830
In practice since 2006 (20 years)
NPI: 1033182951 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dao from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dao? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dao

Dr. Michael Dao is a family medicine specialist in Garden Grove, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dao performed 508 Medicare services across 227 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dao received a total of $48,333 from 70 pharmaceutical and/or device companies across 910 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dao is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 42% volume in CA $48,333 industry payments

Medicare Practice Summary

Medicare Utilization ↗
508
Medicare services
Top 42% in CA for family medicine
227
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~25 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
361 $84 $165
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
90 $58 $145
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
20 $27 $28
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
20 $140 $200
Influenza vaccine, quadrivalent, 0.5 ml dosage 17 $20 $35
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$48,333
Total received (2018-2024)
Avg $6,905/year across 7 years
Top 1% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
910
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$48,333 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$8,796
2023
$7,284
2022
$6,486
2021
$6,259
2020
$3,541
2019
$9,207
2018
$6,760

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,819
Amgen Inc.
$1,153
ABBVIE INC.
$937
GlaxoSmithKline, LLC.
$569
Boehringer Ingelheim Pharmaceuticals, Inc.
$498
Phathom Pharmaceuticals, Inc.
$473
Gilead Sciences, Inc.
$339
Novo Nordisk Inc
$317
Lilly USA, LLC
$268
Ardelyx, Inc.
$260
Vanda Pharmaceuticals Inc.
$250
Axsome Therapeutics, Inc.
$247
Corcept Therapeutics
$238
Merck Sharp & Dohme LLC
$222
Janssen Pharmaceuticals, Inc
$165
Otsuka America Pharmaceutical, Inc.
$155
IRONWOOD PHARMACEUTICALS, INC
$145
RedHill Biopharma Inc.
$144
CeQur Corporation
$96
AIMMUNE THERAPEUTICS, INC.
$62
Radius Health, Inc.
$60
Medtronic, Inc.
$54
Lundbeck LLC
$49
PFIZER INC.
$44
Zimmer Biomet Holdings, Inc.
$40
Kowa Pharmaceuticals America, Inc.
$37
GENZYME CORPORATION
$37
Baxter Healthcare
$37
Bayer Healthcare Pharmaceuticals Inc.
$22
REVANCE THERAPEUTICS, INC.
$20
Paratek Pharmaceuticals, Inc.
$19
Exact Sciences Corporation
$19
Top 3 companies account for 44.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$6,694
Amgen Inc.
$6,100
Janssen Pharmaceuticals, Inc
$3,815
GlaxoSmithKline, LLC.
$3,408
Boehringer Ingelheim Pharmaceuticals, Inc.
$3,406
Gilead Sciences, Inc.
$2,344
Novo Nordisk Inc
$2,177
Lilly USA, LLC
$2,109
AbbVie Inc.
$2,012
ABBVIE INC.
$1,595
Allergan Inc.
$1,293
AbbVie, Inc.
$944
Ironwood Pharmaceuticals, Inc
$896
Amarin Pharma Inc.
$779
Nestle HealthCare Nutrition Inc.
$650
Radius Health, Inc.
$626
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$625
PFIZER INC.
$490
Phathom Pharmaceuticals, Inc.
$473
Merck Sharp & Dohme LLC
$444
Merck Sharp & Dohme Corporation
$443
Novartis Pharmaceuticals Corporation
$443
SANOFI-AVENTIS U.S. LLC
$439
Bayer HealthCare Pharmaceuticals Inc.
$391
Corcept Therapeutics
$367
Allergan, Inc.
$319
Bayer Healthcare Pharmaceuticals Inc.
$281
Abbott Laboratories
$264
Ardelyx, Inc.
$260
Biohaven Pharmaceuticals, Inc.
$251
Vanda Pharmaceuticals Inc.
$250
Axsome Therapeutics, Inc.
$247
Xeris Pharmaceuticals, Inc.
$237
CeQur Corporation
$214
Paratek Pharmaceuticals, Inc.
$176
Bard Peripheral Vascular, Inc.
$173
Avanir Pharmaceuticals, Inc.
$170
Dexcom, Inc.
$158
Otsuka America Pharmaceutical, Inc.
$155
Edwards Lifesciences Corporation
$152
IRONWOOD PHARMACEUTICALS, INC
$145
RedHill Biopharma Inc.
$144
Biohaven Pharmaceutical Holding Company Ltd.
$138
Horizon Pharma plc
$125
Sunovion Pharmaceuticals Inc.
$121
INTERCEPT PHARMACEUTICALS, INC.
$117
Intercept Pharmaceuticals, Inc.
$117
Lexicon Pharmaceuticals, Inc.
$116
Synergy Pharmaceuticals Inc
$109
Lundbeck LLC
$89
UCB, Inc.
$79
Takeda Pharmaceuticals U.S.A., Inc.
$74
Janssen Biotech, Inc.
$68
AIMMUNE THERAPEUTICS, INC.
$62
Baxter Healthcare
$61
NESTLE HEALTHCARE NUTRITION INC.
$61
Avion Pharmaceuticals
$61
IBSA Pharma Inc.
$58
Medtronic, Inc.
$54
Zimmer Biomet Holdings, Inc.
$40
Kowa Pharmaceuticals America, Inc.
$37
GENZYME CORPORATION
$37
DEXCOM, INC.
$34
OptiNose US, Inc.
$20
Oyster Point Pharma, Inc.
$20
REVANCE THERAPEUTICS, INC.
$20
Exact Sciences Corporation
$19
Mylan Specialty L.P.
$18
Genentech USA, Inc.
$17
INTRA-SANA LABORATORIES
$3
Top 3 companies account for 34.4% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO · ANORO ELLIPTA · APTIOM · AREXVY · Aimovig · Amitiza · Auvelity · BEXSERO · BREZTRI · BRILINTA · BYDUREON · Balcoltra · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CREON · CeQur Simplicity · Cimzia · Cologuard Collection Kit · Creon · DAXXIFY · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · DUPIXENT · DUZALLO · Dexcom G6 Transmitter · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Epclusa · FANAPT · FARXIGA · FREESTYLE LIBRE 3 · GARDASIL · GVOKE HYPOPEN · Gel-One Cross-linked Hyaluronate · Hillrom - Life 2000 Ventilation System · Hillrom - Monarch Airway Clearance System · IBSRELA · INVOKANA · Inpefa · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · Korlym · LINZESS · LOKELMA · LYRICA · Linzess · MAVYRET · MINIMED 780G · MOUNJARO · Mavyret · NAMZARIC · NUEDEXTA · NURTEC ODT · NUZYRA · OCALIVA · ORILISSA · Otezla · Ozempic · Prolia · QULIPTA · RECORLEV · RELISTOR · RELTONE 200 MG · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SIMPONI · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · SYMBICORT · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · TYRVAYA · Talicia · Tirosint · Tresiba · Trulance · Tymlos · UBRELVY · VERQUVO · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Vemlidy · Victoza · Wegovy · XARELTO · XIFAXAN · Xhance · Xofluza · Xultophy 100/3.6 · YUPELRI · ZENPEP · ZORYVE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in CA.

Looking for a family medicine specialist in Garden Grove?
Compare family medicine physicians in the Garden Grove area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
2,924
Per 100K population
92.4
County median income
$113,702
Nearest hospital
GARDEN GROVE HOSPITAL & MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dao is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 1% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Dao experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Dao performed 361 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dao receive payments from pharmaceutical companies?
Yes. Dr. Dao received a total of $48,333 from 70 companies across 910 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dao's costs compare to other family medicine physicians in Garden Grove?
Dr. Dao's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dao) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →